This partnership was made possible through a CQDM Connect-Pharma call for proposals, an initiative that gives Canadian companies and researchers the opportunity to directly engage with CQDM’s international pharmaceutical members.
CQDM plays a unique role as a facilitator of healthcare innovation, going well beyond financial investment. Thanks to its strong connections with major pharmaceutical players and its active presence across Canada, CQDM helps accelerate the development of groundbreaking therapies by bringing the right partners together at the right time.
💬 ” We are excited to have brought this collaboration together, and believe that due to the de-risked nature of the AmacaThera technology this project can advance rapidly and generate valuable data in a short period of time.” – Mark Steedman, Senior Business Development Director at CQDM
Read the full press release 👉 https://lnkd.in/eiFsnTbb
Congratulations to AmacaThera on its upcoming collaboration with a leading global pharmaceutical company!
